Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Basu

Showing results (161-170 of 183) with videos related to

Pageof 19
Sort By:
BMC Health Services Research|January 28, 2022
Modernising physician resource planning: a national interactive web platform for Canadian medical traineesD Bourcier, B W Collins, S M Tanya, et al.
International Journal of Cancer|September 22, 2016
A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastomaBrian H Kushner, Nai-Kong V Cheung, Shakeel Modak, et al.
Indian Journal of Biochemistry & Biophysics|December 1, 1990
Carbohydrate and hydrophobic-carbohydrate recognition sites (CARS and HY-CARS) in solubilized glycosyltransferasesS Basu, S Ghosh, M Basu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1996
Functional contributions of the FcepsilonRIalpha and FepsilonRIgamma subunit domains in FcepsilonRI-mediated signaling in mast cellsB Repetto, G Bandara, H Kado-Fong, et al.
Journal of Leukocyte Biology|May 1, 1992
Characterization and use of monoclonal and polyclonal antibodies against the mouse interferon-gamma receptorR D LeClaire, M Basu, D M Pinson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2019
Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective TrialDana L Casey, Brian H Kushner, Nai-Kong V Cheung, et al.
Cancer|March 3, 2015
Osteochondroma in long-term survivors of high-risk neuroblastomaBrian H Kushner, Stephen S Roberts, Danielle N Friedman, et al.
The Journal of Biological Chemistry|June 25, 1993
Purification and characterization of human recombinant IgE-Fc fragments that bind to the human high affinity IgE receptorM Basu, J Hakimi, E Dharm, et al.
Frontiers in Oncology|January 23, 2023
Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS diseaseChristina Fong, Brian H Kushner, Angela Di Giannatale, et al.
Oncotarget|December 2, 2015
Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoinBrian H Kushner, Irina Ostrovnaya, Irene Y Cheung, et al.
Pageof 19

Showing results (161-170 of 183) with videos related to

Sort By:
Pageof 19
BMC Health Services Research|January 28, 2022
Modernising physician resource planning: a national interactive web platform for Canadian medical traineesD Bourcier, B W Collins, S M Tanya, et al.
International Journal of Cancer|September 22, 2016
A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastomaBrian H Kushner, Nai-Kong V Cheung, Shakeel Modak, et al.
Indian Journal of Biochemistry & Biophysics|December 1, 1990
Carbohydrate and hydrophobic-carbohydrate recognition sites (CARS and HY-CARS) in solubilized glycosyltransferasesS Basu, S Ghosh, M Basu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1996
Functional contributions of the FcepsilonRIalpha and FepsilonRIgamma subunit domains in FcepsilonRI-mediated signaling in mast cellsB Repetto, G Bandara, H Kado-Fong, et al.
Journal of Leukocyte Biology|May 1, 1992
Characterization and use of monoclonal and polyclonal antibodies against the mouse interferon-gamma receptorR D LeClaire, M Basu, D M Pinson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2019
Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective TrialDana L Casey, Brian H Kushner, Nai-Kong V Cheung, et al.
Cancer|March 3, 2015
Osteochondroma in long-term survivors of high-risk neuroblastomaBrian H Kushner, Stephen S Roberts, Danielle N Friedman, et al.
The Journal of Biological Chemistry|June 25, 1993
Purification and characterization of human recombinant IgE-Fc fragments that bind to the human high affinity IgE receptorM Basu, J Hakimi, E Dharm, et al.
Frontiers in Oncology|January 23, 2023
Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS diseaseChristina Fong, Brian H Kushner, Angela Di Giannatale, et al.
Oncotarget|December 2, 2015
Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoinBrian H Kushner, Irina Ostrovnaya, Irene Y Cheung, et al.
Pageof 19